文献速递药疹与重症皮肤不良反应

Stevens-Johnson综合征与中毒性表皮坏死松解症30天再入院的预测因素:横断面数据库研究

Predictors of 30-day readmission in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cross-sectional database study.
PubMed 文献 · J Am Acad Dermatol · 2019-09-19

本研究基于2010-2014年全国再入院数据库的8837例SJS/TEN指数住院,发现910例(10.3%)发生30天再入院,再入院诊断以系统性感染(22.0%)、SJS/TEN(20.6%)和皮肤感染(9.1%)为主。与再入院相关的因素包括45-64岁、医疗补助保险、非都市医院入院,以及HIV/AIDS、胶原血管病和转移性癌症等合并症。中位每次再入院费用为10,019美元。

要点

  • SJS/TEN住院后30天再入院率为10.3%,常因感染或疾病复发。
  • 年龄45-64岁、医疗补助保险、非都市医院及特定合并症增加再入院风险。
  • 再入院经济负担显著,中位每次费用10,019美元。

核心结论

  • SJS/TEN住院后30天再入院常见,需识别高危患者以改善出院后连续性照护。

研究设计与样本

  • 横断面研究,使用2010-2014年全国再入院数据库,纳入8837例SJS/TEN指数住院。

主要发现

  • 910例(10.3%)发生30天再入院。
  • 再入院诊断包括系统性感染(22.0%)、SJS/TEN(20.6%)、皮肤感染(9.1%)。
  • 相关因素:年龄45-64岁(OR 1.88,95%CI 1.43-2.49)、医疗补助保险(OR 1.83,95%CI 1.48-2.27)、非都市医院(OR 1.67,95%CI 1.31-2.13)。
  • 合并症:HIV/AIDS(OR 2.48,95%CI 1.63-3.75)、胶原血管病(OR 2.38,95%CI 1.88-3.00)、转移性癌症(OR 2.16,95%CI 1.35-3.46)。
  • 中位每次再入院费用10,019美元(IQR 4,788-16,485美元)。

临床怎么用

  • 对具有高危因素(如年龄45-64岁、医疗补助保险、特定合并症)的SJS/TEN出院患者加强随访和感染监测。

局限性

  • 全国再入院数据库无法跨日历年追踪同一患者。
  • 诊断代码对住院<3天的特异性不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The predictors of readmission in Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) have not been characterized. OBJECTIVE: To determine the variables predictive of 30-day readmission after SJS/TEN hospitalization. METHODS: We performed a cross-sectional study of the 2010-2014 Nationwide Readmissions Database. Bivariate and multivariable logistic regression was used to evaluate associations of patient demographics, comorbidities, and hospital characteristics with readmission. Aggregate and per-readmission costs were calculated. RESULTS: There were 8837 index admissions with SJS/TEN reported; of these, 910 (10.3%) were readmitted, with diagnoses including systemic infection (22.0%), SJS/TEN (20.6%), and cutaneous infection (9.1%). Associated characteristics included age 45 to 64 years (odds ratio [OR], 1.88; 95% confidence interval [CI], 1.43-2.49), Medicaid insurance (OR, 1.83; 95% CI, 1.48-2.27), and nonmetropolitan hospital admission (OR, 1.67; 95% CI, 1.31-2.13). Associated comorbidities included HIV/AIDS (OR, 2.48; 95% CI, 1.63-3.75), collagen vascular disease (OR, 2.38; 95% CI, 1.88-3.00), and metastatic cancer (OR, 2.16; 95% CI, 1.35-3.46). The median per-readmission cost was $10,019 (interquartile range, $4,788-$16,485). LIMITATIONS: The Nationwide Readmissions Database lacks the ability to track the same patient across calendar years. The diagnostic code lacks specificity for hospitalizations <3 days. CONCLUSIONS: Thirty-day readmissions after SJS/TEN hospitalizations are common. Dedicated efforts to identify at-risk patients may improve peridischarge continuity.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Guzman AK, Zhang M, Kwatra SG, et al. Predictors of 30-day readmission in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cross-sectional database study. J Am Acad Dermatol. 2019. PMID: 31542405. doi:10.1016/j.jaad.2019.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。